Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
Abstract Background The efficacy of checkpoint blockade immunotherapies in colorectal cancer is currently restricted to a minority of patients diagnosed with mismatch repair-deficient tumors having high mutation burden. However, this observation does not exclude the existence of neoantigen-specific...
Main Authors: | Jitske van den Bulk, Els M. E. Verdegaal, Dina Ruano, Marieke E. Ijsselsteijn, Marten Visser, Ruud van der Breggen, Thomas Duhen, Manon van der Ploeg, Natasja L. de Vries, Jan Oosting, Koen C. M. J. Peeters, Andrew D. Weinberg, Arantza Farina-Sarasqueta, Sjoerd H. van der Burg, Noel F. C. C. de Miranda |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Genome Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13073-019-0697-8 |
Similar Items
-
In vivo vaccination with cell line-derived whole tumor lysates: neoantigen quality, not quantity matters
by: Inken Salewski, et al.
Published: (2020-10-01) -
The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
by: Els M. E. Verdegaal, et al.
Published: (2017-09-01) -
Factors associated with measles vaccination status in children under the age of three years in a post-soviet context: a cross-sectional study using the DHS VII in Armenia
by: Annabell C. Kantner, et al.
Published: (2021-03-01) -
Additional Evidence on Serological Correlates of Protection against Measles: An Observational Cohort Study among Once Vaccinated Children Exposed to Measles
by: Tom Woudenberg, et al.
Published: (2019-10-01) -
A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry
by: Marieke E. Ijsselsteijn, et al.
Published: (2019-10-01)